Free Stock Analysis
Enter a symbol to receive your free analysis
Is AKTS a Buy, Sell, or Hold?
This is the only report that tells you:
What AKTS is really worth
How safe AKTS really is
Whether AKTS is a Buy, Sell or Hold
Business Description
Aktis Oncology, Inc. is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies. The company was founded by Todd Foley, Patrick Baeuerle and Brian Goodman in August 2020 and is headquartered in Boston, MA.
Aktis Oncology (AKTS)
3 Month Chart
Check VectorVest Before You Invest!